文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肿瘤微环境调控纳米医学设计以对抗多药耐药肿瘤。

Tumor microenvironment-regulating nanomedicine design to fight multi-drug resistant tumors.

机构信息

Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, People's Republic of China.

Breast Center, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.

出版信息

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Jan;15(1):e1842. doi: 10.1002/wnan.1842. Epub 2022 Aug 21.


DOI:10.1002/wnan.1842
PMID:35989568
Abstract

The tumor microenvironment (TME) is a very cunning system that enables tumor cells to escape death post-traditional antitumor treatments through the comprehensive effect of different factors, thereby leading to drug resistance. Deep insights into TME characteristics and tumor resistance encourage the construction of nanomedicines that can remodel the TME against drug resistance. Tremendous interest in combining TME-regulation measurement with traditional tumor treatment to fight multidrug-resistant tumors has been inspired by the increasing understanding of the role of TME reconstruction in improving the antitumor efficiency of drug-resistant tumor therapy. This review focuses on the underlying relationships between specific TME characteristics (such as hypoxia, acidity, immunity, microorganisms, and metabolism) and drug resistance in tumor treatments. The exciting antitumor activities strengthened by TME regulation are also discussed in-depth, providing solutions from the perspective of nanomedicine design. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease Nanotechnology Approaches to Biology > Nanoscale Systems in Biology.

摘要

肿瘤微环境(TME)是一个非常狡猾的系统,它通过不同因素的综合作用,使肿瘤细胞能够在传统抗肿瘤治疗后免于死亡,从而导致耐药性。深入了解 TME 特征和肿瘤耐药性,鼓励构建能够重塑 TME 以抵抗耐药性的纳米药物。随着对 TME 重构在提高耐药性肿瘤治疗抗肿瘤效率中的作用的认识不断加深,人们对将 TME 调节测量与传统肿瘤治疗相结合以对抗多药耐药肿瘤的兴趣大增。本综述重点关注特定 TME 特征(如缺氧、酸度、免疫、微生物和代谢)与肿瘤治疗中耐药性之间的潜在关系。还深入讨论了 TME 调节增强的令人兴奋的抗肿瘤活性,从纳米医学设计的角度提供了解决方案。本文属于以下类别: 治疗方法和药物发现 > 新兴技术 治疗方法和药物发现 > 用于肿瘤疾病的纳米医学 纳米技术在生物学中的应用 > 生物学中的纳米级系统

相似文献

[1]
Tumor microenvironment-regulating nanomedicine design to fight multi-drug resistant tumors.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023-1

[2]
Remodeling tumor microenvironment with nanomedicines.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021-11

[3]
Nanoparticle drug delivery systems responsive to tumor microenvironment: Promising alternatives in the treatment of triple-negative breast cancer.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024

[4]
Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021-9

[5]
Improved cancer immunotherapy strategies by nanomedicine.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023

[6]
Engineering metal-phenolic networks for enhancing cancer therapy by tumor microenvironment modulation.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023

[7]
Responsive Role of Nanomedicine in the Tumor Microenvironment and Cancer Drug Resistance.

Curr Med Chem. 2023

[8]
Organoids technology for advancing the clinical translation of cancer nanomedicine.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023

[9]
Strategies targeting tumor immune and stromal microenvironment and their clinical relevance.

Adv Drug Deliv Rev. 2022-4

[10]
Cell surface-nanoengineering for cancer targeting immunoregulation and precise immunotherapy.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023

引用本文的文献

[1]
Synthesis, Characterization, HSA/DNA Binding, and Cytotoxic Activity of [RuCl(η--cymene)(bph-κ)] Complex.

Molecules. 2025-7-23

[2]
Removing Barriers to Tumor 'Oxygenation': Depleting Glutathione Nanozymes in Cancer Therapy.

Int J Nanomedicine. 2025-5-1

[3]
Role of the TME in immune checkpoint blockade resistance of non-small cell lung cancer.

Cancer Drug Resist. 2024-12-16

[4]
Engineering Stimuli-Responsive Materials for Precision Medicine.

Small. 2025-1

[5]
Delivery of Avocado Seed Extract Using Novel Charge-Switchable Mesoporous Silica Nanoparticles with Galactose Surface Modified to Target Sorafenib-Resistant Hepatocellular Carcinoma.

Int J Nanomedicine. 2024

[6]
Targeted Drug Delivery Strategies for the Treatment of Hepatocellular Carcinoma.

Molecules. 2024-9-16

[7]
The application of bacteria-nanomaterial hybrids in antitumor therapy.

J Nanobiotechnology. 2024-9-4

[8]
Writers, readers, and erasers RNA modifications and drug resistance in cancer.

Mol Cancer. 2024-8-30

[9]
Photodynamic therapy for cancer: mechanisms, photosensitizers, nanocarriers, and clinical studies.

MedComm (2020). 2024-6-22

[10]
Fluorinated Cell-Penetrating Peptide for Co-Delivering siHIF-1α and Sorafenib to Enhance In Vitro Anti-Tumor Efficacy.

Pharmaceutics. 2023-12-16

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索